LNSR

LENSAR, Inc. LNSR

LNSR
LENSAR, Inc. OWLT
Owlet, Inc. AVR
Anteris Technologies Global Corp. MXCT
MaxCyte, Inc. PROF
Profound Medical Corp. RPID
Rapid Micro Biosystems, Inc. ARAY
Accuray Incorporated TLSI
TriSalus Life Sciences, Inc. ANIK
Anika Therapeutics, Inc. CRDF
Cardiff Oncology, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode LNSR OWLT AVR MXCT PROF RPID ARAY TLSI ANIK CRDF
6M -1.87 % 84.08 % 32.00 % -31.63 % 11.19 % 1.44 % -17.07 % 42.97 % -13.78 % -35.14 %
YTD 38.78 % 189.09 % -10.81 % -64.58 % -4.43 % 258.05 % -47.69 % 49.00 % -41.33 % -43.66 %
1Y 52.85 % 171.22 % -12.54 % -65.57 % 4.28 % 232.08 % -46.60 % 94.75 % -42.78 % -55.14 %
3Y 307.43 % 22.01 % -11.61 % -71.12 % -17.58 % 130.07 % -47.96 % -26.10 % -66.92 % 92.00 %
5Y 51.89 % -90.82 % -11.61 % -91.35 % -59.50 % -83.55 % -78.11 % -29.47 % -77.38 % -89.05 %
10Y 34.00 % -90.63 % -11.61 % -91.35 % -22.25 % -83.55 % -85.61 % -29.47 % -74.85 % -99.39 %
From the beginning 34.00 % -90.63 % -11.61 % -91.35 % -22.25 % -83.55 % -96.42 % -29.47 % 171.71 % -99.85 %

Dividend